The somatotropic axis in short children born small for gestational age: relation to insulin resistance.

To determine whether hyperinsulinemia and reduced insulin sensitivity in individuals born small for gestational age (SGA) could be related to persisting abnormalities of the GH/IGF-I axis, we assessed overnight GH secretory profiles and measured fasting glucose, insulin, intact and 32,33 split proin...

Full description

Bibliographic Details
Main Authors: Woods, K, van Helvoirt, M, Ong, K, Mohn, A, Levy, J, de Zegher, F, Dunger, D
Format: Journal article
Language:English
Published: 2002
_version_ 1797059477419065344
author Woods, K
van Helvoirt, M
Ong, K
Mohn, A
Levy, J
de Zegher, F
Dunger, D
author_facet Woods, K
van Helvoirt, M
Ong, K
Mohn, A
Levy, J
de Zegher, F
Dunger, D
author_sort Woods, K
collection OXFORD
description To determine whether hyperinsulinemia and reduced insulin sensitivity in individuals born small for gestational age (SGA) could be related to persisting abnormalities of the GH/IGF-I axis, we assessed overnight GH secretory profiles and measured fasting glucose, insulin, intact and 32,33 split proinsulin, and IGF-I levels in 16 short SGA children (age range 2.3-8.0 y) and in controls. Insulin sensitivity was calculated using the homeostasis model. Compared with short normal-birthweight controls (n = 7, age range 2.3-5.0 y), short SGA children had higher fasting insulin levels (means: 26.8 vs 20.6 pmol/L, p = 0.02), lower insulin sensitivity [means: 204 vs 284 %homeostasis model assessment (HOMA), p = 0.01], and higher beta cell function (112 vs 89 %HOMA, p = 0.04). SGA children also had lower levels of IGFBP-1 (87.0 vs 133.8, p = 0.04), but similar IGF-I levels (IGF-I SDS: -1.1 vs -1.7, p = 0.4). Compared with normal-height controls (n = 15, age range 5.6-12.1 y), SGA children had higher overnight GH secretion (GH maximum: 55.9 vs 39.6 mU/L, p = 0.01; mean: 13.1 vs 8.9, p = 0.004; minimum: 1.2 vs 0.6, p = 0.02). Interestingly, among SGA children, fasting insulin levels and insulin sensitivity were significantly related to overnight GH secretion (insulin sensitivity vs maximum GH: r = -0.68, p = 0.01; vs GH pulse amplitude r = -0.71, p = 0.007). The only hormone level significantly related to current height velocity was C-peptide (r = 0.75, p = 0.008). In conclusion, elevated fasting insulin levels and reduced insulin sensitivity in short SGA children was related to elevated levels of overnight GH secretion. We hypothesize that resistance to the somatotropic actions of GH and IGF-I in short SGA children may contribute directly to reduced insulin sensitivity.
first_indexed 2024-03-06T20:04:48Z
format Journal article
id oxford-uuid:28901417-4a45-46a8-9f11-8a053052bb39
institution University of Oxford
language English
last_indexed 2024-03-06T20:04:48Z
publishDate 2002
record_format dspace
spelling oxford-uuid:28901417-4a45-46a8-9f11-8a053052bb392022-03-26T12:13:37ZThe somatotropic axis in short children born small for gestational age: relation to insulin resistance.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:28901417-4a45-46a8-9f11-8a053052bb39EnglishSymplectic Elements at Oxford2002Woods, Kvan Helvoirt, MOng, KMohn, ALevy, Jde Zegher, FDunger, DTo determine whether hyperinsulinemia and reduced insulin sensitivity in individuals born small for gestational age (SGA) could be related to persisting abnormalities of the GH/IGF-I axis, we assessed overnight GH secretory profiles and measured fasting glucose, insulin, intact and 32,33 split proinsulin, and IGF-I levels in 16 short SGA children (age range 2.3-8.0 y) and in controls. Insulin sensitivity was calculated using the homeostasis model. Compared with short normal-birthweight controls (n = 7, age range 2.3-5.0 y), short SGA children had higher fasting insulin levels (means: 26.8 vs 20.6 pmol/L, p = 0.02), lower insulin sensitivity [means: 204 vs 284 %homeostasis model assessment (HOMA), p = 0.01], and higher beta cell function (112 vs 89 %HOMA, p = 0.04). SGA children also had lower levels of IGFBP-1 (87.0 vs 133.8, p = 0.04), but similar IGF-I levels (IGF-I SDS: -1.1 vs -1.7, p = 0.4). Compared with normal-height controls (n = 15, age range 5.6-12.1 y), SGA children had higher overnight GH secretion (GH maximum: 55.9 vs 39.6 mU/L, p = 0.01; mean: 13.1 vs 8.9, p = 0.004; minimum: 1.2 vs 0.6, p = 0.02). Interestingly, among SGA children, fasting insulin levels and insulin sensitivity were significantly related to overnight GH secretion (insulin sensitivity vs maximum GH: r = -0.68, p = 0.01; vs GH pulse amplitude r = -0.71, p = 0.007). The only hormone level significantly related to current height velocity was C-peptide (r = 0.75, p = 0.008). In conclusion, elevated fasting insulin levels and reduced insulin sensitivity in short SGA children was related to elevated levels of overnight GH secretion. We hypothesize that resistance to the somatotropic actions of GH and IGF-I in short SGA children may contribute directly to reduced insulin sensitivity.
spellingShingle Woods, K
van Helvoirt, M
Ong, K
Mohn, A
Levy, J
de Zegher, F
Dunger, D
The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
title The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
title_full The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
title_fullStr The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
title_full_unstemmed The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
title_short The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
title_sort somatotropic axis in short children born small for gestational age relation to insulin resistance
work_keys_str_mv AT woodsk thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT vanhelvoirtm thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT ongk thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT mohna thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT levyj thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT dezegherf thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT dungerd thesomatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT woodsk somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT vanhelvoirtm somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT ongk somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT mohna somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT levyj somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT dezegherf somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance
AT dungerd somatotropicaxisinshortchildrenbornsmallforgestationalagerelationtoinsulinresistance